WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients. Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday. So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses. “It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.” |
Ashanti and Nelly's relationship timeline: A look at the couple's onRuud advances to Barcelona semis after beating Arnaldi in straight setsEmiliano Martinez is shown TWO yellow cards but littleRepublican Wisconsin Senate candidate says he doesn't oppose elderly people votingJAN MOIR: Another day, another desperate Montecito dollar. This time with jam on it!A former Russian tycoon who once led separatist region launches a hunger strike in Azerbaijan jailThai leaders ready to increase humanitarian aid in Myanmar — Radio Free AsiaHungary's Orbán launches EU election campaign with pledge to 'occupy Brussels'American Express profits jump 34%, helped by jump in new customers, higher spendingEmiliano Martinez is shown TWO yellow cards but little